cours de bourse
14/08/2009 - 11:07:23|49.66 EUR 0.42 %
Stallergenes shareholders approve the project to combine the activities of the Group and Greer Laboratories
> Read more
Positive performance in all geographic regions
Significant growth in the...
Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world.
Stallergenes’ comprehensive approach to allergic diseases includes a complete portfolio combining diagnosis products and treatments and a new generation of allergen immunotherapy treatments.